Randomized, Double-blind, Freeze-Dried MVA-BN ® Lot Consistency Smallpox Vaccine Trial in Healthy, Vaccinia-naïve Subjects
Condition: Smallpox Intervention: Biological: FD MVA-BN Sponsors: Bavarian Nordic; Biomedical Advanced Research and Development Authority Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 8, 2018 Category: Research Source Type: clinical trials
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of Imvamune Smallpox Vaccine
COPENHAGEN, Denmark, February 6, 2018 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced positive results from a Phase 3 pivotal study of its investigational, non-replicating smallpox vaccine, Imvamune. The study achieved both of its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 6, 2018 Category: Pharmaceuticals Source Type: clinical trials
IMVAMUNE ® Smallpox Vaccine in Adult Healthcare Personnel at Risk for Monkeypox in the Democratic Republic of the Congo
Condition: Monkeypox Virus Infection Intervention: Biological: IMVAMUNE® Sponsors: Centers for Disease Control and Prevention; Ministry of Public Health, Democratic Republic of the Congo; Kinshasa School of Public Health; Bavarian Nordic Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2016 Category: Research Source Type: clinical trials